−1.6912USD
−16.08 MUSD
1.73 MUSD
25.49 M
About Pressure BioSciences, Inc.
Sector
Industry
CEO
Richard T. Schumacher
Website
Headquarters
South Easton
Employees (FY)
17
Founded
1978
ISIN
US74112E2081
FIGI
BBG000HKMCF9
Pressure BioSciences, Inc. engages in the development, marketing, and sale of proprietary laboratory instrumentation and associated consumables. The firm’s products include high pressure barocyclers and barozyme, high pressure generators and accessories, mini ultra-high pressure pump, barocycler and barozyme accessories, microtube accessories for barocyclers and barozyme, high pressure cell disruptors from constant systems, and service contracts. It offers its products under the brands Barocycler, PULSE, BioSeq, ProteoSolve, ProteoSolveLRS, Power of PCT, PCT Shredder, HUB440, HUB880, micro- Pestle, PCT-HD, BaroFold, Barozyme, BaroFlex and Strips. The company was founded by Richard T. Schumacher in August 1978 and is headquartered in South Easton, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PBIO is 0.2560 USD — it has decreased by 5.08% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Pressure BioSciences, Inc. stocks are traded under the ticker PBIO.
Pressure BioSciences, Inc. is going to release the next earnings report on Apr 16, 2024. Keep track of upcoming events with our Earnings Calendar.
PBIO stock is 19.58% volatile and has beta coefficient of −5.98. Check out the list of the most volatile stocks — is Pressure BioSciences, Inc. there?
Yes, you can track Pressure BioSciences, Inc. financials in yearly and quarterly reports right on TradingView.
PBIO stock has fallen by 17.42% compared to the previous week, the month change is a 81.56% rise, over the last year Pressure BioSciences, Inc. has showed a 75.38% decrease.
PBIO net income for the last quarter is −5.63 M USD, while the quarter before that showed −6.92 M USD of net income which accounts for 18.67% change. Track more Pressure BioSciences, Inc. financial stats to get the full picture.
Today Pressure BioSciences, Inc. has the market capitalization of 6.59 M, it has increased by 25.05% over the last week.
No, PBIO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PBIO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pressure BioSciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 17.00 employees. See our rating of the largest employees — is Pressure BioSciences, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pressure BioSciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pressure BioSciences, Inc. stock shows the sell signal. See more of Pressure BioSciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pressure BioSciences, Inc. EBITDA is −7.29 M USD, and current EBITDA margin is −269.76%. See more stats in Pressure BioSciences, Inc. financial statements.